Dorian (Gast)
| | I can't get a signal ?levaquin mg Getting a partner for Spedra in Europe will take the heat off Vivus management for a little while as it prepares to fend off pressure from its major shareholder, First Manhattan Co, for control of the firm. The latter has been disparaging about the disappointing launch of the obesity drug Qsymia (phentermine/topiramate) and is looking to get its slate of directors elected to the board at the annual general meeting next week.
|